The role of airway macrophages in apoptotic cell clearance following acute and chronic lung inflammation
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Acute and chronic inflammatory responses in the lung are associated with the accumulation of large quantities of immune and structural cells undergoing apoptosis, which need to be engulfed by phagocytes in a process called 'efferocytosis'. Apoptotic cell recognition and removal from the lung is mediated predominantly by airway macrophages, though immature dendritic cells and non-professional phagocytes, such as epithelial cells and mesenchymal cells, can also display this function. Efficient clearance of apoptotic cells from the airways is essential for successful resolution of inflammation and the return to lung homeostasis. Disruption of this process leads to secondary necrosis of accumulating apoptotic cells, release of necrotic cell debris and subsequent uncontrolled inflammatory activation of the innate immune system by the released 'damage associated molecular patterns' (DAMPS). To control the duration of the immune response and prevent autoimmune reactions, anti-inflammatory signalling cascades are initiated in the phagocyte upon apoptotic cell uptake, mediated by a range of receptors that recognise specific phospholipids or proteins externalised on, or secreted by, the apoptotic cell. However, prolonged activation of apoptotic cell recognition receptors, such as the family of receptor tyrosine kinases Tyro3, Axl and MerTK (TAM), may delay or prevent inflammatory responses to subsequent infections. In this review, we will discuss recent advances in our understanding of the mechanism controlling apoptotic cell recognition and removal from the lung in homeostasis and during inflammation, the contribution of defective efferocytosis to chronic inflammatory lung diseases, such as chronic obstructive pulmonary disease, asthma and cystic fibrosis, and implications of the signals triggered by apoptotic cells in the susceptibility to pulmonary microbial infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., & Henson, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1112 · Cited by 3,166 · cited 2×
“Efferocytosis also upregulates prostaglandin E2 (PGE2) and impairs FcRmediated phagocytosis [54, 56], and intratracheal instillation of apoptotic cells enhances the resolution of LPSinduced acute pulmonary inflammation [57].”
BackgroundA Lineage of Myeloid Cells Independent of Myb and Hematopoietic Stem Cells
Schulz, C., Perdiguero, E. G., Chorro, L., Szabo-Rogers, H., Cagnard, N., Kierdorf, K., Prinz, M., Wu, B., Jacobsen, S. E. W., Pollard, J. W., et al. (2012) · Science · doi:10.1126/science.1219179 · Cited by 2,578 · cited 1×
“come YFP expressing and so mice do not require prior manipulation to distinguish resident versus recruited airway cells [66].”
BackgroundImmunosuppressive effects of apoptotic cells
Voll, R. E., Herrmann, M., Roth, E. A., Stach, C., Kalden, J. R., & Girkontaite, I. (1997) · Nature · doi:10.1038/37022 · Cited by 1,787
Lambrecht, B. N., & Hammad, H. (2015) · Nature Immunology · doi:10.1038/ni.3049 · Cited by 1,673 · cited 1×
“tissue-resident mast cells, which release a broad array of inflammatory mediators promoting migration of eosinophils into the airways [92].”
BackgroundNucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance
Elliott, M. R., Chekeni, F. B., Trampont, P. C., Lazarowski, E. R., Kadl, A., Walk, S. F., Park, D., Woodson, R. I., Ostankovich, M., Sharma, P., et al. (2009) · Nature · doi:10.1038/nature08296 · Cited by 1,654 · cited 1×
“The distinction between apoptotic and healthy cells is mediated primarily by the release of ‘find-me’ signals from apoptotic cells that include ATP and UTP [3], fractalkine (CX3CL1) [4], lysophosphatidylcholine [5] and sphingosine-1-phosphate [6].”
BackgroundAlveolar macrophages: plasticity in a tissue-specific context
Hussell, T., & Bell, T. J. (2014) · Nature Reviews Immunology · doi:10.1038/nri3600 · Cited by 1,377 · cited 1×
“Furthermore, mucus bathing the epithelium contains surfactant proteins that dampen macrophage responsiveness in health [62].”
BackgroundSelf-citationIdentification of Tim4 as a phosphatidylserine receptor
Miyanishi, M., Tada, K., Koike, M., Uchiyama, Y., Kitamura, T., & Nagata, S. (2007) · Nature · doi:10.1038/nature06307 · Cited by 1,180 · cited 1×
“Externalised PtdSer is recognised directly by triggering receptor expressed by myeloid cells-2 (TREM2) [30] , CD300 [31] , receptor for advanced glycation end products (RAGE) [32] , stabilin-2 [33] , brain-specific angiogenesis inhibitor-1 (BAI1) [34] and the family of T cell/transmembrane, immunoglobulin, and mucin (…”
BackgroundTakahashi, K., Rochford, C. D. P., & Neumann, H. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041611 · Cited by 1,124
TAM Receptors Are Pleiotropic Inhibitors of the Innate Immune Response
Rothlin, C. V., Ghosh, S., Zuniga, E. I., Oldstone, M. B. A., & Lemke, G. (2007) · Cell · doi:10.1016/j.cell.2007.10.034 · Cited by 1,055 · cited 1×
“For example, engagement and activation of TAM receptors inhibits signalling pathways triggered by cytokines and toll-like receptor ligands through induction of suppressor of cytokine signalling-1 and 3 (SOCS-1 and 3) [49, 50] (see Fig.”
BackgroundLauber, K., Bohn, E., Kröber, S. M., Xiao, Y.-J., Blumenthal, S. G., Lindemann, R. K., Marini, P., Wiedig, C., Zobywalski, A., Baksh, S., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00422-7 · Cited by 967
Phagocytosis of apoptotic cells in homeostasis
Arandjelovic, S., & Ravichandran, K. S. (2015) · Nature Immunology · doi:10.1038/ni.3253 · Cited by 959
Barclay, A. N., & van den Berg, T. K. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120142 · Cited by 841
Flow Cytometric Analysis of Macrophages and Dendritic Cell Subsets in the Mouse Lung
Misharin, A. V., Morales-Nebreda, L., Mutlu, G. M., Budinger, G. R. S., & Perlman, H. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0086ma · Cited by 838
Lemke, G. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009076 · Cited by 598 · cited 1×
“For example, integrin αvβ3 or αvβ5 requires MFG-E8, while Tyro3, Axl and MerTK that form the TAM receptor tyrosine kinase family [37] require the bridging molecules Protein S or growth arrest specific 6 (Gas6) [38] .”
BackgroundBeginnings of a Good Apoptotic Meal: The Find-Me and Eat-Me Signaling Pathways
Ravichandran, K. S. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.004 · Cited by 559
A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia
Hsieh, C. L., Koike, M., Spusta, S. C., Niemi, E. C., Yenari, M., Nakamura, M. C., & Seaman, W. E. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06042.x · Cited by 475
CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis
Truman, L. A., Ford, C. A., Pasikowska, M., Pound, J. D., Wilkinson, S. J., Dumitriu, I. E., Melville, L., Melrose, L. A., Ogden, C. A., Nibbs, R., et al. (2008) · Blood · doi:10.1182/blood-2008-06-162404 · Cited by 473
Hodge, S., Hodge, G., Scicchitano, R., Reynolds, P. N., & Holmes, M. (2003) · Immunology & Cell Biology · doi:10.1046/j.1440-1711.2003.t01-1-01170.x · Cited by 440 · cited 1×
“Uptake of apoptotic bronchial epithelial cells and neutrophils is significantly reduced in bronchoalveolar lavage macrophages from patients with COPD compared to healthy controls [21, 22, 79] , and this defect is more pronounced in COPD patients who currently smoke [22] .”
BackgroundDepletion of alveolar macrophages during influenza infection facilitates bacterial superinfections
Ghoneim, H. E., Thomas, P. G., & McCullers, J. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300014 · Cited by 394 · cited 1×
“For example, in case of Mycobacterium tuberculosis (Mtb) infections, necrosis of infected cells leads to dissemination of bacteria, whereas engulfment of infected cells undergoing apoptosis allows for pathogen destruction airways from the periphery during influenza infection contract by Fas-dependent apoptosis, while…”
BackgroundApoptosis disables CD31-mediated cell detachment from phagocytes promoting binding and engulfment
Brown, S., Heinisch, I., Ross, E., Shaw, K., Buckley, C. D., & Savill, J. (2002) · Nature · doi:10.1038/nature00811 · Cited by 390 · cited 2×
“Furthermore, healthy cells prevent engulfment by expressing CD47 and CD31 [15, 16] or by ligating CD300a that impedes macrophage function [17].”
BackgroundEfferocytosis Is an Innate Antibacterial Mechanism
Martin, C. J., Booty, M. G., Rosebrock, T. R., Nunes-Alves, C., Desjardins, D. M., Keren, I., Fortune, S. M., Remold, H. G., & Behar, S. M. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.06.010 · Cited by 285
TREM-2 promotes macrophage survival and lung disease after respiratory viral infection
Wu, K., Byers, D. E., Jin, X., Agapov, E., Alexander-Brett, J., Patel, A. C., Cella, M., Gilfilan, S., Colonna, M., Kober, D. L., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141732 · Cited by 207 · cited 1×
“TREM2 Confirmed in mice [23] and humans [24]”
BackgroundYoon, Y.-S., Kim, S.-Y., Kim, M.-J., Lim, J.-H., Cho, M.-S., & Kang, J. L. (2015) · Mucosal Immunology · doi:10.1038/mi.2014.130 · Cited by 145
Fractalkine-Induced MFG-E8 Leads to Enhanced Apoptotic Cell Clearance by Macrophages
Miksa, M., Amin, D., Wu, R., Dong, W., Ravikumar, T. S., & Wang, P. (2007) · Molecular Medicine · doi:10.2119/2007-00019.miksa · Cited by 118 · cited 1×
“For example, apoptotic cell production of fractalkine induces milk fat globule-epidermal growth factor 8 (MFG-E8) expression in phagocytes that enhances apoptotic cell clearance [7].”
BackgroundLee, Y.-J., Moon, C., Lee, S. H., Park, H.-J., Seoh, J.-Y., Cho, M.-S., & Kang, J. L. (2012) · European Respiratory Journal · doi:10.1183/09031936.00096711 · Cited by 60 · cited 2×
“liorates fibrosis and inflammation in bleomycin-induced lung injury in mice [58, 114], indicating that signalling triggered by apoptotic cell recognition may play a protective role in lung”
Background
Cited by
Harrell, C. R., Jovicic, N., Djonov, V., Arsenijevic, N., & Volarevic, V. (2019) · Cells · doi:10.3390/cells8121605 · Cited by 795
“MSC-Exos significantly decreased iNOS mRNA expression and remarkable increased expression of Arginase-1 mRNA in alveolar macrophages, inducing their polarization from inflammatory M1 towards immunosuppressive M2 phenotype [50,55].”
BackgroundInfluentialHow macrophages deal with death
Lemke, G. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0167-y · Cited by 433
Suthahar, N., Meijers, W. C., Silljé, H. H. W., & de Boer, R. A. (2017) · Current Heart Failure Reports · doi:10.1007/s11897-017-0343-y · Cited by 307
“The phagocytosed particle can influence phenotypic characteristics of macrophages [24, 25]; for instance, macrophages assume a more fibrotic (M2) phenotype after ingesting apoptotic neutrophils [26].”
BackgroundA human circulating immune cell landscape in aging and COVID-19
Zheng, Y., Liu, X., Le, W., Xie, L., Li, H., Wen, W., Wang, S., Ma, S., Huang, Z., Ye, J., et al. (2020) · Protein & Cell · doi:10.1007/s13238-020-00762-2 · Cited by 270
Phagocytosis imprints heterogeneity in tissue-resident macrophages
A-Gonzalez, N., Quintana, J. A., García-Silva, S., Mazariegos, M., González de la Aleja, A., Nicolás-Ávila, J. A., Walter, W., Adrover, J. M., Crainiciuc, G., Kuchroo, V. K., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20161375 · Cited by 282
Metadata
- Authors
- Grabiec, A. M., & Hussell, T.
- Venue
- Seminars in Immunopathology
- Published
- 2016-03-08
- Volume
- 38
- Issue
- 4
- Pages
- 409-423
- ISSN
- 1863-2297 (ISSN-L)
- 1863-2300
- OpenAlex
- W2294987993
- Cited by
- 145
- References
- 25
- FWCI
- 9.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.